awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26801292-01AAA8B5-67F2-4467-9B15-468A653C8A5B
Q26801292-01AAA8B5-67F2-4467-9B15-468A653C8A5B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26801292-01AAA8B5-67F2-4467-9B15-468A653C8A5B
New developments in the treatment of chronic lymphocytic leukemia: role of obinutuzumab
P2860
Q26801292-01AAA8B5-67F2-4467-9B15-468A653C8A5B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26801292-01AAA8B5-67F2-4467-9B15-468A653C8A5B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
298d6bf1e6fab95aee87a98eb440d2cb98aed4c0
P2860
Obinutuzumab plus fludarabine/cyclophosphamide or bendamustine in the initial therapy of CLL patients: the phase 1b GALTON trial.